Latest News for: Pharmaceutical sources

Edit

Hemogenyx Pharmaceuticals PLC Announces Final Results

Pharmiweb 25 Apr 2024
LONDON, UK / ACCESSWIRE / April 25, 2024 / Hemogenyx Pharmaceuticals plc (LSE.HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces its final audited results for the year ended 31 December 2023.
Edit

Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)

The Call 24 Apr 2024
Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate 'BH3120' in combination with KEYTRUDA in phase 1 clinical trial in patients with progressive or metastatic solid tumors ... SOURCE Hanmi Pharmaceutical.
Edit

Ukraine attack drones strike Russia energy sites

Naharnet 24 Apr 2024
Ukrainian drones attacked oil facilities in western Russia overnight, defense sources in Kyiv confirmed Wednesday, in the latest aerial assault by Kyiv aiming to dent Russian military logistics.
Edit

AI Hallucinations Are not Always bad – They Can Create New Antibiotics

Cryptopolitan 24 Apr 2024
Source ... “SyntheMol created structures and chemical recipes for six novel drugs aimed at killing resistant strains of Acinetobacter baumannii, one of the leading pathogens responsible for antibacterial resistance-related deaths.” Source.
Edit

CNS Pharmaceuticals to Present at the LSX World Congress 2024

ACCESSWIRE 23 Apr 2024
Presentation on Monday, April 29 th at 4.15 PM (GMT+1) HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc ... About CNS Pharmaceuticals, Inc ... Investor Relations Contact JTC Team, LLC Jenene Thomas 833-475-8247 CNSP@jtcir.com SOURCE.
Edit

Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health

ACCESSWIRE 23 Apr 2024
About Petros Pharmaceuticals Petros Pharmaceuticals is committed to the goal of becoming a leading innovator in the emerging self-care market driving expanded access to key prescription pharmaceuticals as Over-the-Counter treatment options.
Edit

6.5 million metric tons of sargassum is heading toward Florida again. What to know

Pensacola News Journal 23 Apr 2024
Sargassum washing up on Pensacola Beach just before Memorial Day ... Tony Giberson, Pensacola News Journal ... The floating algae serves as a marine resource, too, providing uses as biomass for food, fuel and a possible source of pharmaceutical materials.
Edit

CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity

Pharmiweb 22 Apr 2024
HOUSTON, TX / ACCESSWIRE / April 22, 2024 / CNS Pharmaceuticals, Inc ... Pharmaceuticals will present at the Virtual Investor Lunch Break ... About CNS Pharmaceuticals, Inc ... SOURCE. CNS Pharmaceuticals, Inc.
Edit

Omega-3 Market Is Estimated To be Worth USD 2,682 Million by 2032-end at a CAGR of 4.80%

Pharmiweb 22 Apr 2024
This market includes the extraction and processing of omega-3 fatty acids from both marine and plant sources, catering to a wide range of applications such as dietary supplements, functional foods and beverages, pharmaceuticals, and infant nutrition.
Edit

Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)

GetNews 22 Apr 2024
Biotech Stocks in focus include Actinium Pharmaceuticals, Inc ... One biotech company that we would like to draw your attention to is Actinium Pharmaceuticals, Inc ... Sources..
Edit

CBG Oils – The Best 7 CBG Oil Brands to Buy Online in 2024

The Tribune Greeley 22 Apr 2024
$64.99 to $119.99, balancing affordability and potency Full-spectrum composition preserves cannabinoids, terpenes, flavonoids Superior plant sourcing and stringent quality standards Scientific, ...
Edit

9 Palestinians killed in Israeli airstrike on Gaza's Rafah

China.dot.org 20 Apr 2024
... Palestinian medical sources said on Saturday. The sources told Xinhua that six of the dead were children, and rescue workers were searching for people still buried in rubble.
Edit

Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split

ACCESSWIRE 19 Apr 2024
BOSTON, MA / ACCESSWIRE / April 19, 2024 / Pieris Pharmaceuticals, Inc ... About Pieris Pharmaceuticals ... Pieris Pharmaceuticals, Inc. info@pieris.com SOURCE. Pieris Pharmaceuticals, Inc.
Edit

NLS Pharmaceutics Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request Hearing

ACCESSWIRE 19 Apr 2024
Z�RICH, SWITZERLAND / ACCESSWIRE / April 19, 2024 / NLS Pharmaceutics Ltd ... About NLS Pharmaceutics Ltd. NLS Pharmaceutics Ltd ... Investor Relations Contact InvestorRelations@nls-pharma.com www.nlspharmaceutics.com SOURCE.
Edit

Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty

GetNews 19 Apr 2024
ABBV), Actinium Pharmaceuticals (NYSE AMERICAN ... Actinium Pharmaceuticals, Inc ... Recently, Actinium Pharmaceuticals (NYSE AMERICAN ... Actinium Pharmaceuticals (NYSE AMERICAN ... Sources..

Most Viewed

Donald Trump
Jabin Botsford/The Washington Post via AP, Pool / The Washington Post
Estonian Tax and Customs Board`s new Nuctech mobile Xray (36425971793)
Creative Commons / EU2017EE Estonian Presidency https://www.flickr.com/people/145047505@N06
File - In this image provided by the U.S. Army, U.S. Army Sgt. Ian Ketterling, gunner for Alpha Battery, 1st Battalion, 3rd Field Artillery Regiment, 17th Field Artillery Brigade, prepares the crane for loading the Army Tactical Missile System (ATACMS) on to the High Mobility Artillery Rocket System (HIMARS) in Queensland, Australia, July 26, 2023. U.S. officials say Ukraine for the first time has begun using long-range ballistic missiles, called ATACMS, striking a Russian military airfield in Crimea and Russian troops in another occupied area overnight.
AP / Sgt. 1st Class Andrew Dickson/U.S. Army via AP
U.S. Secretary of State Antony Blinken, left, talks with Shanghai Party Secretary Chen Jining at the Grand Halls, Thursday, April 25, 2024, in Shanghai, China.
AP Photo/Mark Schiefelbein, Pool / Copyright 2024 The Associated Press. All rights reserved.
Hungarian Prime Minister Viktor Orban
Creative Commons / Vlada Republike Slovenije https://creativecommons.org/licenses/by-sa/4.0/deed.en
×